325 Capital LLC
In its 13F for Q1 2024 (holdings as of March 31, 2024, filed May 15, 2024), 325 Capital LLC reported 12 stock positions worth $216.6 million. Its top holding was Blue Bird (BLBD) at 20.6% of the portfolio, followed by Astronics (ATRO, 14.4%) and iShares 0-3 Month Treasury B (SGOV, 13.2%). Compared with Q4 2023, it sold out of 1 and added to 1. The biggest buy was Lifecore Biomedical (LFCR, shares +11%) and the biggest sale an exit from Daseke (DSKE).
- Most Recent 13F
- Q2 2026
- Location
- NEW YORK, NY
- CIK
- 0001873893
- Portfolio Value
- $216.6M (Q1 2024)
- SEC Filing
- 0001214659-24-009288 ↗ filed May 15, 2024
Holdings Value
Holdings 12 stocks · $216.6M
| BLBD Blue Bird Corp. | 20.61% | 1,164,207 | $44.6M | No change |
| ATRO Astronics Corp. | 14.39% | 1,636,188 | $31.2M | No change |
| SGOV iShares 0-3 Month Treasury B | 13.21% | 284,137 | $28.6M | No change |
| ASTH Astrana Health Inc. | 11.49% | 592,810 | $24.9M | No change |
| BTMD Biote Corp. Class A | 10.09% | 3,766,666 | $21.8M | No change |
| APEI American Public Education | 8.41% | 1,283,284 | $18.2M | No change |
| MPAA Motorcar Parts of America Inc. | 5.22% | 1,405,057 | $11.3M | No change |
| IDCC Interdigital Inc. | 4.62% | 93,966 | $10.0M | No change |
| COHU Cohu Inc. | 3.34% | 216,823 | $7.2M | No change |
| LFCR Lifecore Biomedical Inc. | 3.29% | 1,340,598 | $7.1M | Add +11.1% |
| HTLD Heartland Express Inc. | 2.89% | 523,404 | $6.2M | No change |
| TACT Transact Technologies Inc. | 2.45% | 1,011,789 | $5.3M | No change |
Portfolio Sells Q4 2023 → Q1 2024
| DSKE Daseke Inc. | Sold out | 0.00% | −3.34 |
Portfolio Buys Q4 2023 → Q1 2024
| LFCR Lifecore Biomedical Inc. | Add +11.1% | 3.29% | −0.41 |
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 12 | $419.5M | ASTH, MGNI, APEI, BLBD, SPIR |
| Q1 2026 | 12 | $274.5M | APEI, ASTH, BLBD, MGNI, SPIR |
| Q4 2025 | 13 | $285.4M | APEI, ASTH, MGNI, BLBD, MPAA |
| Q3 2025 | 12 | $329.1M | ATRO, APEI, BLBD, ASTH, MPAA |
| Q2 2025 | 11 | $253.3M | APEI, ATRO, BLBD, MPAA, SPIR |
| Q1 2025 | 11 | $241.4M | APEI, ATRO, ASTH, BLBD, AIOT |
| Q4 2024 | 12 | $258.7M | APEI, BLBD, BTMD, ASTH, ATRO |
| Q3 2024 | 11 | $236.2M | ASTH, BLBD, ATRO, APEI, BTMD |
| Q2 2024 | 13 | $238.1M | BLBD, ATRO, BTMD, ASTH, APEI |
| Q1 2024 | 12 | $216.6M | BLBD, ATRO, SGOV, ASTH, BTMD |